<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Topics tagged with neurobiology]]></title><description><![CDATA[A list of topics that have been tagged with neurobiology]]></description><link>https://board.circlewithadot.net/tags/neurobiology</link><generator>RSS for Node</generator><lastBuildDate>Fri, 15 May 2026 04:07:54 GMT</lastBuildDate><atom:link href="https://board.circlewithadot.net/tags/neurobiology.rss" rel="self" type="application/rss+xml"/><pubDate>Invalid Date</pubDate><ttl>60</ttl><item><title><![CDATA[Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue.]]></title><description><![CDATA[Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.#Neuroscience #Neurobiology #ClinicalNeurology #sflorghttps://www.sflorg.com/2026/05/ns05122601.html]]></description><link>https://board.circlewithadot.net/topic/b756ce9c-fd7c-439a-9a5d-c2322afa3821/anti-nogo-a-therapy-utilizes-a-novel-monoclonal-antibody-ng101-to-stimulate-the-regeneration-of-damaged-spinal-cord-tissue.</link><guid isPermaLink="true">https://board.circlewithadot.net/topic/b756ce9c-fd7c-439a-9a5d-c2322afa3821/anti-nogo-a-therapy-utilizes-a-novel-monoclonal-antibody-ng101-to-stimulate-the-regeneration-of-damaged-spinal-cord-tissue.</guid><dc:creator><![CDATA[sflorg@mastodon.social]]></dc:creator><pubDate>Invalid Date</pubDate></item></channel></rss>